Characteristics and performance of minority-serving dialysis facilities.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4024357)

Published in Health Serv Res on December 20, 2013

Authors

Yoshio N Hall1, Ping Xu, Glenn M Chertow, Jonathan Himmelfarb

Author Affiliations

1: Kidney Research Institute, University of Washington, Seattle, WA.

Articles cited by this

Race, gender, and partnership in the patient-physician relationship. JAMA (1999) 13.80

Primary care physicians who treat blacks and whites. N Engl J Med (2004) 12.23

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med (1998) 11.58

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA (1999) 9.97

Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med (2003) 9.29

Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA (2011) 7.04

The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med (1999) 6.02

Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82

Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57

The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33

End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09

Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67

The quality of medical care. Science (1978) 3.93

Rural definitions for health policy and research. Am J Public Health (2005) 3.87

Concentration and quality of hospitals that care for elderly black patients. Arch Intern Med (2007) 2.84

Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med (2007) 2.33

Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol (2009) 2.21

Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol (2007) 1.98

Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol (1999) 1.92

Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health Aff (Millwood) (2011) 1.91

The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87

Performance measurement in search of a path. N Engl J Med (2007) 1.78

Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol (1998) 1.68

Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol (2000) 1.62

Separate and unequal: clinics where minority and nonminority patients receive primary care. Arch Intern Med (2009) 1.60

Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. J Am Soc Nephrol (2005) 1.55

Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol (2012) 1.36

Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med (2006) 1.25

African American and non-African American patients' and families' decision making about renal replacement therapies. Qual Health Res (2012) 1.09

Imperial or empirical measures of dialysis quality? Am J Kidney Dis (2007) 1.09

Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes. Am J Kidney Dis (2009) 1.09

Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care? Arch Intern Med (2007) 1.07

The 2011 ESRD prospective payment system: an uncontrolled experiment. Am J Kidney Dis (2011) 1.05

Ethnic differences in the use of peritoneal dialysis as initial treatment for end-stage renal disease. JAMA (1995) 1.04

Medicare program; end-stage renal disease quality incentive program. Final rule. Fed Regist (2011) 0.98

End-stage renal disease measures of quality. Annu Rev Med (2007) 0.94

Early nephrology referral is associated with prolonged survival in hemodialysis patients even after exclusion of lead-time bias. Am J Med Sci (2010) 0.91

Cost, quality, and value: the changing political economy of dialysis care. J Am Soc Nephrol (2007) 0.87

Prevalence of pre-end-stage renal disease care and associated outcomes among urban, micropolitan, and rural dialysis patients. Am J Nephrol (2013) 0.84

Articles by these authors

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40

Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA (2002) 7.20

Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol (2008) 6.91

Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86

Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66

Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45

Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04

Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science (2004) 5.64

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28

Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med (2011) 5.11

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95

Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72

Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell (2008) 4.51

Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell (2010) 4.32

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96

Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol (2008) 3.93

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med (2002) 3.92

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol (2002) 3.83

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83

Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med (2007) 3.80

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics (2006) 3.56

Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol (2012) 3.51

Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med (2011) 3.11

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10

Nephrology consultation in acute renal failure: does timing matter? Am J Med (2002) 2.95

Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92

A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet (2011) 2.85

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int (2004) 2.81

Acute renal failure definitions and classification: time for change? J Am Soc Nephrol (2003) 2.81

Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts. Clin Cancer Res (2009) 2.79

Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol (2002) 2.74

Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol (2011) 2.65

Significance of frailty among dialysis patients. J Am Soc Nephrol (2007) 2.62

Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol (2011) 2.62

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61

An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health (2009) 2.60

Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55

Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54

Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52

Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51

Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50

Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer (2011) 2.42

Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med (2009) 2.39

Donor kidney exchanges. Am J Transplant (2004) 2.39

The case against calcium-based phosphate binders. Clin J Am Soc Nephrol (2006) 2.38

Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr (2004) 2.37

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res (2007) 2.35

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol (2013) 2.28

Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26

Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol (2013) 2.26

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23

Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr (2003) 2.19

Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10

Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med (2012) 2.10

The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem (2008) 2.09

Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol (2007) 2.07

Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc (2006) 2.04

Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysis. Clin J Am Soc Nephrol (2011) 2.02

Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med (2010) 2.00

Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res (2008) 1.99

Acute kidney injury and mortality in hospitalized patients. Am J Nephrol (2012) 1.99

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int (2005) 1.96

Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int (2002) 1.96

Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell (2008) 1.94

Enhanced 2,3-butanediol production by Klebsiella pneumoniae SDM. Appl Microbiol Biotechnol (2008) 1.92

Control of hypertension in adults with chronic kidney disease in the United States. Hypertension (2005) 1.92

Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant (2011) 1.92

Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91

Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol (2006) 1.91

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90

A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis (2012) 1.90

The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis (2006) 1.86

Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. Nephrol Dial Transplant (2011) 1.85

Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology (2008) 1.83

Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis (2003) 1.83

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int (2010) 1.83

Balancing Fistula First with Catheters Last. Am J Kidney Dis (2007) 1.83